I
Immunovant, Inc. (IMVT)
NMS – Real vaqt narxi. Valyuta: USD
38.85
+0.61 (1.60%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
38.84
-0.01 (-0.03%)
Bozordan keyin: Jun 26, 2026, 5:32 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NMS – Real vaqt narxi. Valyuta: USD
38.85
+0.61 (1.60%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
38.84
-0.01 (-0.03%)
Bozordan keyin: Jun 26, 2026, 5:32 PM EDT
Immunovant, Inc., klinik immunologiya kompaniyasi, otoimmün kasalliklari bo'lgan odamlarning ehtiyojlarini qondirish uchun maqsadli davolash usullarini ishlab chiqadi. U IMVT-1402, yuvenil kristalizatsiya qilinadigan Fc retseptorini inhibe qiluvchi inson monoklonal antitelasini ishlab chiqadi, bu Graves kasalligi, revmatoid artrit, Sjögren sindromi, teri qizil yug'irig'i, miyasteniya gravis va surunkali yallig'lanishli demiyelinatsiyalovchi polinevropatiya uchun ishlatiladi. Kompaniya 2018-yilda tashkil etilgan va Shimoliy Karolinaning Dyurham shahrida joylashgan. Immunovant, Inc. Roivant Sciences Ltd. sho'ba korxonasi sifatida faoliyat yuritadi.
| Ism | Lavozim |
|---|---|
| Dr. Eric Venker M.D., Pharm.D. | CEO & Director |
| Dr. Frank M. Torti M.B.A., M.D. | Executive Chairperson of the Board |
| Dr. Jay S. Stout M.S., Ph.D. | Chief Technology Officer |
| Mr. Christopher A. Van Tuyl Esq., J.D. | Chief Legal Officer & Corporate Secretary |
| Mr. Tiago M. Girao CPA | Chief Financial Officer |
| Ms. Christine Blodgett | Senior Vice President of Human Resources |
| Ms. Melanie Gloria B.S.N. | Chief Operating Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-20 | 8-K | imvt-20260520.htm |
| 2026-05-20 | 10-K | imvt-20260331.htm |
| 2026-02-06 | 10-Q | imvt-20251231.htm |
| 2025-12-12 | 8-K | d68980d8k.htm |
| 2025-12-11 | 8-K | d760155d8k.htm |
| 2025-11-21 | 8-K | imvt-20251121.htm |
| 2025-11-10 | 8-K | imvt-20251110.htm |
| 2025-09-03 | 8-K | imvt-20250903.htm |
| 2025-08-28 | 8-K | imvt-20250827.htm |
| 2025-08-11 | 8-K | imvt-20250811.htm |